DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes

Show simple item record

dc.contributor.authorKizhakeyil, Atish
dc.contributor.authorZaini, Nurmahirah Binte Mohammed
dc.contributor.authorPoh, Zhi Sheng
dc.contributor.authorWong, Brandon Han Siang
dc.contributor.authorLoh, Xinpeng
dc.contributor.authorNg, Aik Seng
dc.contributor.authorLow, Zun Siong
dc.contributor.authorPrasannan, Praseetha
dc.contributor.authorGong, Chun
dc.contributor.authorTan, Michelle Guet Khim
dc.contributor.authorNagarajan, Chandramouli
dc.contributor.authorHuang, Dachuan
dc.contributor.authorLu, Pang Wan
dc.contributor.authorLim, Jing Quan
dc.contributor.authorBarrans, Sharon
dc.contributor.authorOng, Choon Kiat
dc.contributor.authorLim, Soon Thye
dc.contributor.authorChng, Wee Joo
dc.contributor.authorFollows, George
dc.contributor.authorHodson, Daniel J.
dc.contributor.authorDu, Ming Qing
dc.contributor.authorGoh, Yeow Tee
dc.contributor.authorTan, Suat Hoon
dc.contributor.authorGrigoropoulos, Nicholas Francis
dc.contributor.authorVerma, Navin Kumar
dc.date.accessioned2021-10-18T08:50:19Z
dc.date.available2021-10-18T08:50:19Z
dc.date.issued2021-10-16
dc.date.submitted2021-07-27
dc.identifier.others12943-021-01437-0
dc.identifier.other1437
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/329546
dc.descriptionFunder: addenbrooke's charitable trust, cambridge university hospitals; doi: http://dx.doi.org/10.13039/501100002927
dc.languageen
dc.publisherBioMed Central
dc.subjectLetter to the Editor
dc.subjectDDX3X mutation
dc.subjectHematolymphoid malignancy
dc.subjectPrognosis
dc.subjectTumour metastasis
dc.subjectDrug resistance
dc.titleDDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes
dc.typeOther
dc.date.updated2021-10-18T08:50:18Z
prism.issueIdentifier1
prism.publicationNameMolecular Cancer
prism.volume20
dc.identifier.doi10.17863/CAM.76994
dcterms.dateAccepted2021-09-24
rioxxterms.versionofrecord10.1186/s12943-021-01437-0
rioxxterms.versionVoR
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by/4.0/
dc.contributor.orcidVerma, Navin Kumar [0000-0002-5940-6633]
dc.identifier.eissn1476-4598
pubs.funder-project-idnanyang technological university (L0412290)
pubs.funder-project-idministry of education - singapore (MOE2017-T2-2-004)
pubs.funder-project-idnational medical research council (OFLCG18May-0028, NMRC/TA/0051/2016)
pubs.funder-project-idkay kendall leukaemia fund (KKL649)
pubs.funder-project-idmedical research council (MR/M008584/1)
pubs.funder-project-idwellcome trust (203151/Z/16/Z)
pubs.funder-project-idcancer research uk (A25117)


Files in this item

Thumbnail
Name:
12943_2021_Article_1437_nlm.xml
Size:
64Kb
Format:
XML
View / Open Files
Thumbnail
Name:
additional-files.zip
Size:
165Kb
Format:
application/zip
View / Open Files
Thumbnail
Name:
12943_2021_Article_1437.pdf
Size:
3Mb
Format:
PDF
View / Open Files
Thumbnail
Name:
12943_2021_1437_MOESM1_ESM.pdf
Size:
766Kb
Format:
PDF
View / Open Files

This item appears in the following Collection(s)

Show simple item record